Form 10-Q SPECTRUM PHARMACEUTICALS For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Spectrum Pharma (SPPI) Tops Q2 EPS by 24c
August 9, 2016 4:53 PM EDTSpectrum Pharma (NASDAQ: SPPI) reported Q2 EPS of ($0.05), $0.24 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $30.9 million versus the consensus estimate of $30.88 million.
Non-GAAP net loss was $0.5 million, or $(0.01) per basic and diluted share in the comparable period in... More
